Significantly lower rates of symptom rebound and rebound severity seen 4 weeks after eradication for those with infection.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback